![Melissa Downs](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profiel
Melissa Downs is currently working as a Senior Director-External Communications at Lantheus Holdings, Inc. She previously worked as an Investor Relations Contact at Progenics Pharmaceuticals, Inc.
Actieve functies van Melissa Downs
Bedrijven | Functie | Begin |
---|---|---|
LANTHEUS HOLDINGS, INC. | Public Communications Contact | 01-08-2020 |
Eerdere bekende functies van Melissa Downs
Bedrijven | Functie | Einde |
---|---|---|
PROGENICS PHARMACEUTICALS, INC. | Investor Relations Contact | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
LANTHEUS HOLDINGS, INC. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Progenics Pharmaceuticals, Inc.
![]() Progenics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Progenics Pharmaceuticals, Inc. engages in the development of medicines and other products for targeting and treating cancer. Its pipeline includes therapeutic agents, imaging agents for prostate cancer, and imaging analysis technology. The company was founded by Paul J. Maddon on December 1, 1986 and is headquartered in New York, NY. | Health Technology |